Literature DB >> 30838378

NFPws: a web server for delineating broadly neutralizing antibody specificities from serum HIV-1 neutralization data.

Nagarajan Raju1,2, Ian Setliff1,3, Ivelin S Georgiev1,2,4,5.   

Abstract

MOTIVATION: A better understanding of antibody responses to HIV-1 infection in humans can provide novel insights for the development of an effective HIV-1 vaccine. Neutralization fingerprinting (NFP) is an efficient and accurate algorithm for delineating the epitope specificities found in polyclonal antibody responses to HIV-1 infection. Here, we report the development of NFPws, a web server implementation of the NFP algorithm. The server takes as input serum neutralization data for a set of diverse viral strains, and uses a mathematical model to identify similarities between the serum neutralization pattern and the patterns for known broadly neutralizing monoclonal antibodies (bNAbs), in order to predict the prevalence of bNAb epitope specificities in the given serum. In addition, NFPws also computes and displays a number of estimates related to prediction confidence, as well as the likelihood of presence of novel, previously uncharacterized, antibody specificities in a given serum. NFPws also implements a JSmol viewer for molecular structure visualization of the prediction results. Overall, the NFPws server will be an important tool for the identification and analysis of epitope specificities of bNAb responses against HIV-1.
AVAILABILITY AND IMPLEMENTATION: NFPws is freely available to access at (http://iglab.accre.vanderbilt.edu/NFPws). The webserver is developed using html, CSS, javascript and perl CGI scripts. The NFP algorithm is implemented with scripts written in octave, linux shell and perl. JSmol is implemented to visualize the prediction results on a representative 3D structure of an HIV-1 antigen.
© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30838378      PMCID: PMC6748713          DOI: 10.1093/bioinformatics/btz097

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  14 in total

1.  Two distinct broadly neutralizing antibody specificities of different clonal lineages in a single HIV-1-infected donor: implications for vaccine design.

Authors:  Mattia Bonsignori; David C Montefiori; Xueling Wu; Xi Chen; Kwan-Ki Hwang; Chun-Yen Tsao; Daniel M Kozink; Robert J Parks; Georgia D Tomaras; John A Crump; Saidi H Kapiga; Noel E Sam; Peter D Kwong; Thomas B Kepler; Hua-Xin Liao; John R Mascola; Barton F Haynes
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

2.  Computational analysis of anti-HIV-1 antibody neutralization panel data to identify potential functional epitope residues.

Authors:  Anthony P West; Louise Scharf; Joshua Horwitz; Florian Klein; Michel C Nussenzweig; Pamela J Bjorkman
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-10       Impact factor: 11.205

Review 3.  Elicitation of HIV-1-neutralizing antibodies against the CD4-binding site.

Authors:  Ivelin S Georgiev; M Gordon Joyce; Tongqing Zhou; Peter D Kwong
Journal:  Curr Opin HIV AIDS       Date:  2013-09       Impact factor: 4.283

4.  HIV-1 VACCINES. Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen.

Authors:  Joseph G Jardine; Takayuki Ota; Devin Sok; Matthias Pauthner; Daniel W Kulp; Oleksandr Kalyuzhniy; Patrick D Skog; Theresa C Thinnes; Deepika Bhullar; Bryan Briney; Sergey Menis; Meaghan Jones; Mike Kubitz; Skye Spencer; Yumiko Adachi; Dennis R Burton; William R Schief; David Nemazee
Journal:  Science       Date:  2015-06-18       Impact factor: 47.728

Review 5.  Insights into the trimeric HIV-1 envelope glycoprotein structure.

Authors:  Andrew B Ward; Ian A Wilson
Journal:  Trends Biochem Sci       Date:  2015-01-16       Impact factor: 13.807

6.  A limited number of antibody specificities mediate broad and potent serum neutralization in selected HIV-1 infected individuals.

Authors:  Laura M Walker; Melissa D Simek; Frances Priddy; Johannes S Gach; Denise Wagner; Michael B Zwick; Sanjay K Phogat; Pascal Poignard; Dennis R Burton
Journal:  PLoS Pathog       Date:  2010-08-05       Impact factor: 6.823

7.  Delineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralization.

Authors:  Ivelin S Georgiev; Nicole A Doria-Rose; Tongqing Zhou; Young Do Kwon; Ryan P Staupe; Stephanie Moquin; Gwo-Yu Chuang; Mark K Louder; Stephen D Schmidt; Han R Altae-Tran; Robert T Bailer; Krisha McKee; Martha Nason; Sijy O'Dell; Gilad Ofek; Marie Pancera; Sanjay Srivatsan; Lawrence Shapiro; Mark Connors; Stephen A Migueles; Lynn Morris; Yoshiaki Nishimura; Malcolm A Martin; John R Mascola; Peter D Kwong
Journal:  Science       Date:  2013-05-10       Impact factor: 47.728

8.  Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interface.

Authors:  Jinghe Huang; Byong H Kang; Marie Pancera; Jeong Hyun Lee; Tommy Tong; Yu Feng; Hiromi Imamichi; Ivelin S Georgiev; Gwo-Yu Chuang; Aliaksandr Druz; Nicole A Doria-Rose; Leo Laub; Kwinten Sliepen; Marit J van Gils; Alba Torrents de la Peña; Ronald Derking; Per-Johan Klasse; Stephen A Migueles; Robert T Bailer; Munir Alam; Pavel Pugach; Barton F Haynes; Richard T Wyatt; Rogier W Sanders; James M Binley; Andrew B Ward; John R Mascola; Peter D Kwong; Mark Connors
Journal:  Nature       Date:  2014-09-03       Impact factor: 49.962

9.  Structure and immune recognition of trimeric pre-fusion HIV-1 Env.

Authors:  Marie Pancera; Tongqing Zhou; Aliaksandr Druz; Ivelin S Georgiev; Cinque Soto; Jason Gorman; Jinghe Huang; Priyamvada Acharya; Gwo-Yu Chuang; Gilad Ofek; Guillaume B E Stewart-Jones; Jonathan Stuckey; Robert T Bailer; M Gordon Joyce; Mark K Louder; Nancy Tumba; Yongping Yang; Baoshan Zhang; Myron S Cohen; Barton F Haynes; John R Mascola; Lynn Morris; James B Munro; Scott C Blanchard; Walther Mothes; Mark Connors; Peter D Kwong
Journal:  Nature       Date:  2014-10-08       Impact factor: 49.962

10.  Identification of broadly neutralizing antibody epitopes in the HIV-1 envelope glycoprotein using evolutionary models.

Authors:  Miguel Lacerda; Penny L Moore; Nobubelo K Ngandu; Michael Seaman; Elin S Gray; Ben Murrell; Mohan Krishnamoorthy; Molati Nonyane; Maphuti Madiga; Constantinos Kurt Wibmer; Daniel Sheward; Robert T Bailer; Hongmei Gao; Kelli M Greene; Salim S Abdool Karim; John R Mascola; Bette T M Korber; David C Montefiori; Lynn Morris; Carolyn Williamson; Cathal Seoighe
Journal:  Virol J       Date:  2013-12-02       Impact factor: 4.099

View more
  3 in total

1.  Envelope characteristics in individuals who developed neutralizing antibodies targeting different epitopes in HIV-1 subtype C infection.

Authors:  Bongiwe Ndlovu; Kamini Gounder; Daniel Muema; Nagarajan Raju; Tandile Hermanus; Qiniso Mthethwa; Kim Robertson; Bruce D Walker; Ivelin S Georgiev; Lynn Morris; Penny L Moore; Thumbi Ndung'u
Journal:  Virology       Date:  2020-03-25       Impact factor: 3.616

2.  B cell engagement with HIV-1 founder virus envelope predicts development of broadly neutralizing antibodies.

Authors:  Samantha M Townsley; Gina C Donofrio; Ningbo Jian; David J Leggat; Vincent Dussupt; Letzibeth Mendez-Rivera; Leigh Anne Eller; Lauryn Cofer; Misook Choe; Philip K Ehrenberg; Aviva Geretz; Syna Gift; Rebecca Grande; Anna Lee; Caroline Peterson; Mary Bryson Piechowiak; Bonnie M Slike; Ursula Tran; M Gordon Joyce; Ivelin S Georgiev; Morgane Rolland; Rasmi Thomas; Sodsai Tovanabutra; Nicole A Doria-Rose; Victoria R Polonis; John R Mascola; Adrian B McDermott; Nelson L Michael; Merlin L Robb; Shelly J Krebs
Journal:  Cell Host Microbe       Date:  2021-03-03       Impact factor: 21.023

3.  Broad and Potent Neutralizing Antibodies Recognize the Silent Face of the HIV Envelope.

Authors:  Till Schoofs; Christopher O Barnes; Nina Suh-Toma; Jovana Golijanin; Philipp Schommers; Henning Gruell; Anthony P West; Franziska Bach; Yu Erica Lee; Lilian Nogueira; Ivelin S Georgiev; Robert T Bailer; Julie Czartoski; John R Mascola; Michael S Seaman; M Juliana McElrath; Nicole A Doria-Rose; Florian Klein; Michel C Nussenzweig; Pamela J Bjorkman
Journal:  Immunity       Date:  2019-05-21       Impact factor: 31.745

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.